Opioid use following partial meniscectomy with needle arthroscopy compared to standard knee arthroscopy: Results from a randomized multicenter trial
Article History
-
Received: ,
Accepted: ,
Abstract
Abstract
To evaluate opioid use following partial meniscectomy performed with needle arthroscopy compared to standard arthroscopy.
A prospective, multicenter randomized trial was performed between January and August 2023. Patients undergoing isolated partial meniscectomy were randomized to receive either needle (NA, n = 41) or standard arthroscopic (SA, n = 40) treatment. Those receiving meniscus repair or concurrent ligament, or cartilage procedures were excluded. The primary outcome was opioid consumption within 24 h post-operatively. Secondary outcomes were patient reported outcomes (PROs), including Knee Injury and Osteoarthritis Outcome (KOOS) pain and International Knee Documentation Committee (IKDC) scores measured at 2, 6, and 12-weeks postoperatively. Univariate analysis was used to compare results.
Eighty-nine patients were enrolled. One patient withdrew on the day of surgery. Eight patients (NA, n = 2; SA, N = 6) were excluded due to insufficient records regarding opioid consumption. There were 41 patients in the NA group and 40 patients in the SA group (NA 26 males, 63 % vs. SA 19 males, 48 %, p = 0.15). Mean age ± SD (NA 48.5 ± 10.7 vs SA 48.2 ± 9.9 years, p = 0.87) and body mass index (NA 30.8 ± 4.9 vs. SA 32.6 ± 6.6 m/kg2, p = 0.64) were not significantly different. Pre-operative Outerbridge scores were similar (NA 2.8 ± 1.1 vs. SA 2.5 ± 1.2, p = 0.38). The NA group consumed significantly fewer opioid pills within 24 h (NA 1.3 ± 1.7 vs. SA 2.7 ± 2.1, p < 0.01). In addition, patients reported significant differences in KOOS pain and IKDC scores at 2 weeks [KOOS pain: NA 62.9 ± 21.2 vs. 50.2 ± 20.1, p = 0.007 and IKDC: NA 56.7 ± 18.7 vs. SA 41 ± 17.2, p < 0.001] and 6 weeks post-operatively [KOOS pain: NA 72.6 ± 20.5 vs. 63.5 ± 18.3, p = 0.050 and IKDC: NA 67.5 ± 23.9 vs. 54.8 ± 18.1, p = 0.015]. At 12 weeks, differences in PROs were not maintained.
In the immediate post-operative period, opioid use was significantly reduced after partial meniscectomy performed with needle arthroscopy compared with standard arthroscopy.
Level I.
Abstract
Highlights of the paper
•Prospective, multicenter randomized trial comparing opioid use and patient reported outcomes following isolated partial meniscectomy with needle.•In the immediate post-operative period, opioid use was significantly reduced after partial meniscectomy performed with needle arthroscopy.
Keywords
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
1 Introduction
Arthroscopic surgery has transformed the treatment of intra-articular knee pathology, evolving from open procedures to highly refined, minimally invasive techniques that enhance visualization, reduce surgical morbidity, and accelerate recovery. One of the most recent and promising innovations in this field is needle arthroscopy (NA), enabling diagnostic and therapeutic procedures under minimal sedation.1–3 In-office needle arthroscopy (IONA) has been utilized for diagnosis of knee and shoulder pathology with success compared to magnetic resonance imaging (MRI).4,5 In addition, surgical indications using NA are expanding; for instance, partial meniscectomy and meniscus repair techniques have been described.6,7 In a recent retrospective study of partial meniscectomy with NA vs. standard instrumentation, pain scores and opioid consumption were found to be significantly improved with NA at 2- and 6-weeks post-operatively.1 (see Table 3)
The potential advantages of NA compared to standard treatment methods require further study with higher level of evidence. Therefore, this study was designed as a multicenter randomized trial comparing outcomes of partial meniscectomy performed with NA vs. traditional arthroscopy. The purpose of the study was to evaluate opioid use following partial meniscectomy performed with needle arthroscopy compared to standard arthroscopy. We hypothesized that the NA group would demonstrate reduced opioid consumption within the first 24 h after surgery.
2 Methods
After IRB approval, a prospective, multicenter randomized was performed between January and August 2023. CONSORT guidelines were used to ensure important methodological information is presented. Ninety patients undergoing isolated partial meniscectomy were prospectively enrolled and randomized to receive either needle or standard arthroscopic treatment. Those receiving meniscus repair, root repair, or concurrent ligament or cartilage procedures were excluded. Patients were treated by two orthopedic surgeons fellowship-trained in sports medicine. Patients were randomized in a 1:1 ratio using a computer-generated algorithm, assigning 45 individuals to either Group NA or SA in a sequentially numbered order. A research assistant prepared the allocation assignments and sealed them in envelopes, which were securely stored and only opened by the operating surgeon at the time of surgical scheduling. Although the surgeon was aware of the assigned treatment, the allocation was not disclosed to the patient. As such, the surgeon was not blinded to group assignment, whereas patients and all research personnel involved in postoperative assessments, including those administering patient-reported outcomes (PROs), remained blinded to the treatment allocation.
Demographic information including age, sex, height, weight, body-mass index, and smoking status were recorded. The Outterbridge classification (OB) was used to quantify the extent of osteoarthritis at the time of surgery. Procedural variables including volume of arthroscopic fluid (milliliters, mL) and tourniquet time (minutes, min) were also recorded for comparison. The primary outcome was opioid consumption (number of pills) within 24 h post-operatively. Secondary outcomes were patient reported outcomes (PROs), including Knee Injury and Osteoarthritis Outcome (KOOS) pain, and International Knee Documentation Committee (IKDC) scores measured at 2, 6, and 12-weeks postoperatively. Patients were seen in the office or contacted by phone at these time points for data collection.
3 Surgical technique
Surgical technique was performed as previously described.1 Briefly, patients were taken to the operating room and placed in the supine position with a well-padded tourniquet on the upper thigh. A leg-holder was used (Zimmer Biomet, Warsaw, IN). The non-operative leg was padded and held in slight flexion. After standard sterile prep, the knee joint was accessed. In the SA group, anterolateral portal incisions were made percutaneously followed by arthroscopic assisted medial incisions. In the NA group, the 1.9 mm NanoScope (Arthrex, Naples, FL) system was inserted without making skin incisions. A spinal needle inserted into the anterolateral joint space just superior to the lateral meniscus with the knee flexed to 90°. A nitinol wire was passed through the needle, which was then withdrawn. A small-diameter cannula was inserted over the wire, after which the wire was removed, and inflow was established. Diagnostic arthroscopy was performed. In the NA group, single-use instrumentation including 2-mm meniscal biters and shavers were used to debride meniscus tears. Chondroplasty was performed as needed. After particle meniscectomy was performed, the remaining arthroscopic joint fluid was aspirated. Local anesthesia was not used in either group. Arthroscopic incisions were closed with 3.0 nylon sutures, while nanoscopic incisions were reapproximated with steri-strips.
In both cohorts, post-operatively, patients were allowed to weight bear as tolerated and started formalized physical therapy between 1 and 14 days. A prescription of hydrocodone-acetaminophen 5–325 mg taken as needed every 4 h was provided. Aspirin 325 mg daily x 2 weeks was prescribed for deep vein thrombosis (DVT) prophylaxis and was not taken as an analgesic.
4 Statistical analysis
Descriptive statistics were utilized to summarize the data. Continuous variables were reported as means with standard deviations (SD), while categorical variables were presented as counts and percentages. Comparisons between continuous variables were made using the student's t-test, and categorical variables were analyzed with Fisher's exact test. A p-value of less than 0.05 was considered statistically significant. All statistical analyses were conducted using Microsoft Excel version 16.43 (Microsoft Corp., Redmond, WA).
5 Results
Overall, eighty-nine patients were enrolled. One patient elected to withdraw on the day of surgery. Eight patients (NA, n = 2; SA, N = 6) were excluded due to insufficient records regarding opioid consumption. In total, there were 41 patients in the NA group and 40 patients in the SA group (NA 26 males, 63 % vs. SA 19 males, 48 %, p = 0.22, Table 1). Mean age ± SD (NA 48.5 ± 10.7 vs SA 48.2 ± 9.9 years, p = 0.87) and body mass index (NA 30.8 ± 4.9 vs. SA 32.6 ± 6.6 m/kg2, p = 0.64) were not significantly different. Pre-operative Outerbridge scores were also comparable (NA 2.8 ± 1.1 vs. SA 2.5 ± 1.2, p = 0.38). Follow-up compliance across all timepoints was 97 %, with minor loss to follow-up (2 patients per group) evenly distributed between groups and timepoints.
| Variable | Group | Mean (SD) | 95 % CI (Lower–Upper) | P-value |
| Sex (male), n (%) | Needle Arthroscopy | 26 (63.4 %) | – | 0.223 |
| Standard Arthroscopy | 19 (47.5 %) | – | ||
| Age (years) | Needle Arthroscopy | 48.5 (10.7) | 45.1–51.9 | 0.866 |
| Standard Arthroscopy | 48.2 (9.9) | 45.0–51.4 | ||
| BMI (kg/m2) | Needle Arthroscopy | 30.8 (4.9) | 29.2–32.3 | 0.644 |
| Standard Arthroscopy | 32.6 (6.6) | 30.5–34.7 | ||
| Outerbridge score | Needle Arthroscopy | 2.8 (1.1) | 2.4–3.1 | 0.375 |
| Standard Arthroscopy | 2.6 (2.3) | 1.9–3.3 | ||
| VAS Score | Needle Arthroscopy | 6.5 (2.2) | 5.8–7.2 | 0.513 |
| Standard Arthroscopy | 6.2 (1.2) | 5.8–6.6 | ||
| IKDC Score | Needle Arthroscopy | 33.6 (14.0) | 29.1–38.1 | 0.887 |
| Standard Arthroscopy | 33.2 (16.2) | 28.1–38.3 | ||
| KOOS Pain | Needle Arthroscopy | 40.0 (19.9) | 33.7–46.3 | 0.927 |
| Standard Arthroscopy | 39.6 (19.1) | 33.6–45.6 | ||
| KOOS Symptoms/Stiffness | Needle Arthroscopy | 48.1 (24.1) | 40.5–55.7 | 0.806 |
| Standard Arthroscopy | 49.4 (23.4) | 42.1–56.7 | ||
| KOOS Functional Daily Living | Needle Arthroscopy | 50.4 (22.0) | 43.7–57.1 | 0.716 |
| Standard Arthroscopy | 52.2 (23.8) | 44.8–59.6 | ||
| KOOS Sports & Recreation | Needle Arthroscopy | 31.2 (22.1) | 24.4–38.0 | 0.433 |
| Standard Arthroscopy | 26.8 (24.2) | 19.1–34.5 | ||
| KOOS Quality of Life | Needle Arthroscopy | 23.3 (22.1) | 16.5–30.1 | 0.900 |
| Standard Arthroscopy | 22.8 (16.1) | 17.7–27.9 |
As anticipated, the volume of arthroscopic fluid utilized during needle arthroscopic partial meniscectomy was significantly lower compared to standard arthroscopy (471 ± 244 mL vs. 1610 ± 805 mL, p < 0.0001). Tourniquet time was comparable between groups (NA: 19.6 ± 5 min; SA: 19 ± 5 min, p = 0.61).
Opioid consumption was found to be lower in the NA group within 24 h (NA 1.3 ± 1.7 vs. SA 2.7 ± 2.1 pills, p < 0.01; 95 %CI (0.76–1.84).
In addition, patients reported significant differences in KOOS pain and IKDC scores at 2 weeks [KOOS pain: NA 62.9 ± 21.2 vs. 50.2 ± 20.1, p = 0.007 and IKDC: NA 56.7 ± 18.7 vs. SA 41 ± 17.2, p < 0.001] and 6 weeks post-operatively [KOOS pain: NA 72.6 ± 20.5 vs. 63.5 ± 18.3, p = 0.050 and IKDC: NA 67.5 ± 23.9 vs. 54.8 ± 18.1, p = 0.015]. At 12 weeks, differences in KOOS pain (NA: 77.7 ± 24.3 vs. SA: 70.4 ± 24.1, p = 0.23) and IKDC scores (NA: 74.4 ± 23.1 vs. SA: 64.0 ± 22.9, p = 0.07) were not maintained (Table 2). No wound site or surgical complications were recorded within the follow-up period.
| Parameter | NA Preoperative | SA Preoperative | NA 2-Week | SA 2-Week | NA 6-Week | SA 6-Week | NA 12-Week | SA 12-Week |
| VAS Score | 6.5 ± 2.2 (5.8–7.2) | 2.6 ± 1.2 (2.2–3.0) | 2.4 ± 2.6 (1.6–3.2) | 3.6 ± 2.6 (2.8–4.4) | 1.7 ± 1.9 (1.1–2.3) | 3.2 ± 2.8 (2.3–4.1) | 2.6 ± 2.8 (1.7–3.5) | 2.6 ± 2.5 (1.8–3.4) |
| IKDC Score | 33.6 ± 14.0 (29.3–37.9) | 33.2 ± 16.2 (28.2–38.2) | 56.7 ± 18.7 (51.0–62.4) | 41.3 ± 17.2 (36.0–46.6) | 67.5 ± 23.9 (60.2–74.8) | 54.8 ± 18.1 (49.2–60.4) | 74.4 ± 23.1 (67.3–81.5) | 64.0 ± 22.9 (56.9–71.1) |
| KOOS Pain | 40.0 ± 19.9 (33.9–46.1) | 39.6 ± 19.1 (33.7–45.5) | 62.9 ± 21.2 (56.4–69.4) | 50.2 ± 20.1 (44.0–56.4) | 72.6 ± 20.5 (66.3–78.9) | 63.5 ± 18.3 (57.8–69.2) | 77.7 ± 24.3 (70.3–85.1) | 70.4 ± 24.1 (62.9–77.9) |
| KOOS Symptoms and Stiffness | 48.1 ± 24.1 (40.7–55.5) | 49.4 ± 23.4 (42.1–56.7) | 68.9 ± 19.2 (63.0–74.8) | 55.3 ± 19.6 (49.2–61.4) | 77.6 ± 18.3 (72.0–83.2) | 72.0 ± 18.8 (66.2–77.8) | 81.3 ± 21.0 (74.9–87.7) | 75.5 ± 22.0 (68.7–82.3) |
| KOOS Functional Daily Living | 50.4 ± 22.0 (43.7–57.1) | 52.2 ± 23.8 (44.8–59.6) | 72.5 ± 21.0 (66.1–78.9) | 59.6 ± 23.0 (52.5–66.7) | 82.7 ± 18.1 (77.2–88.2) | 75.0 ± 19.5 (69.0–81.0) | 86.4 ± 21.1 (79.9–92.9) | 80.2 ± 34.1 (69.6–90.8) |
| KOOS Sports and Rec | 31.2 ± 22.1 (24.4–38.0) | 26.8 ± 24.2 (19.3–34.3) | 49.9 ± 31.9 (40.1–59.7) | 37.1 ± 31.9 (27.2–47.0) | 61.0 ± 31.5 (51.4–70.6) | 45.4 ± 27.9 (36.8–54.0) | 70.0 ± 36.4 (58.9–81.1) | 58.4 ± 34.1 (47.8–69.0) |
| KOOS Quality of Life | 23.3 ± 22.1 (16.5–30.1) | 22.8 ± 16.1 (17.8–27.8) | 53.6 ± 25.4 (45.8–61.4) | 40.8 ± 19.8 (34.7–46.9) | 65.7 ± 26.5 (57.6–73.8) | 54.0 ± 21.8 (47.2–60.8) | 69.6 ± 29.3 (60.6–78.6) | 62.4 ± 25.5 (54.5–70.3) |
| Parameter | NA Mean ± SD (95 % CI) | SA Mean ± SD (95 % CI) | p | Interpretation |
| Arthroscopic fluid (mL) | 471 ± 244 (395–547) | 1610 ± 805 (1356–1864) | <0.0001 | Lower in NA |
| Tourniquet time (min) | 19.6 ± 5 (18.1–21.1) | 19 ± 5 (17.5–20.5) | 0.61 | Comparable |
| Opioid consumption (pills, 24h) | 1.3 ± 1.7 (0.77–1.83) | 2.7 ± 2.1 (2.04–3.36) | <0.01 | Lower in NA |
6 Discussion
These findings suggest that needle arthroscopy (NA) offers significant subjective and objective functional outcomes over standard arthroscopy (SA) for partial meniscectomy in the early postoperative period. Patients in the NA group demonstrated significantly lower opioid consumption within 24 h after surgery which was the main primary outcome of our study. The functional outcome scores, KOOS pain and IKDC scores improved in NA group at 2 and 6 weeks. but W these differences were not maintained at 12 weeks. Early benefits in pain relief and functional recovery may have important implications for rehabilitation timelines and patient satisfaction.
This study expands upon previous retrospective data supporting NA by utilizing a prospective, randomized, multicenter design.1 The results confirm that NA can be performed safely and effectively by experienced arthroscopists, with comparable tourniquet times, no increase in complications, and significantly reduced arthroscopic fluid usage. The reduced tissue trauma associated with NA—achieved through smaller percutaneous portals and single-use instruments—may contribute to decreased postoperative inflammation and pain, thereby facilitating earlier mobilization and reduced reliance on opioid analgesia. These immediate benefits may help patients an early return to work, daily activities, driving and sports, thereby reducing the cost burden.
From a clinical perspective, the main aim is to emphasize the relevance of these study results in the context of ongoing efforts to optimize surgical recovery protocols and address the over-prescription of opioids in orthopedic surgery. Prior studies have reported on opioid overprescribing after common arthroscopic procedures. Studies suggest wide variability in narcotic use after arthroscopic knee surgery, and patients often receive more opioids than needed following routine knee arthroscopy.8,9 This reinforces the need for standardized, data-driven prescribing practices. Multiple factors, can influence pain intensity; however, based on the study's results in the immediate post-operative period, pain following meniscectomy performed with the needle arthroscope was statistically reduced compared to standard instrumentation. Incorporating techniques such as NA into practice may help align with opioid-sparing strategies.
7 Limitations
This study has several limitations. First, although patients and outcome assessors were blinded to treatment allocation, the operating surgeon was not, which may introduce performance bias. Second, we did not perform an a priori power analysis prior to initiating the trial. However, a post hoc power analysis based on observed effect sizes demonstrated that the study was sufficiently powered to detect differences in both opioid consumption and IKDC scores, with achieved power exceeding 90 % for each. Despite this, given the small sample size, there is risk for Type I and Type II error. Additionally, while short-term outcomes favored the needle arthroscopy group, long-term clinical significance remains uncertain and will require further investigation. Opioid consumption data was unavailable for a small subset of patients, although the rate of missing data was low and evenly distributed between groups. Baseline opioid consumption or differences in pain threshold was not recorded. We recognize the subjective nature of pain and many factors mainly existing osteoarthritic changes and meniscal tear pattern that influence its intensity. Due to small sample size we believed univariate analysis would suffice, which may be a statistical shortcoming. Finally, we recognize the risk for sponsorship bias in the present study; however, randomized treatment allocation was performed to limit the risk of selection bias that would favor outcomes in the needle arthroscope group.
8 Conclusion
Needle arthroscopy for partial meniscectomy was associated with significantly lower in immediate and early postoperative opioid consumption and improved short-term functional outcomes compared to standard arthroscopy. These findings support the use of NA as an effective, minimally traumatic, tissue sparing alternative with potential benefits in pain management, functional recovery, and opioid stewardship. Further large sample RCTs are warranted to evaluate long-term outcomes, cost-effectiveness, and broader implementation in diverse clinical settings.
Informed consent
Yes.
Author contributions
Chad D. Lavender MD: Visualization, Investigation, Supervision. Ethan Hahn BS1: Investigation, Formal analysis, Writing- Original draft. Tyler H. Hwang BS3: Investigation, Formal analysis, Writing- Original draft. Andrew L. Schaver MD1: Writing- Original draft, Review and Editing. Eliana S. LeMaster MD2: Writing- Original draft. Review and Editing. James Nottingham FNP-BC: Investigation, Writing- Original draft. Review and Editing. Timothy E. Hewett PhD: Supervision. Evan H. Argintar MD: Visualization, Investigation.
Institutional ethical committee approval
This study was approved by the Investigational Review Board.
Declaration of generative AI and AI-assisted technologies in the writing process
During the preparation of this work the author(s) used Grok in order to assist with manuscript writing. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
Funding/sponsorship
Arthrex, Inc. support through grant # IIRR 01164.
References
- Partial meniscectomy using needle arthroscopy associated with significantly less pain and improved patient reported outcomes at two weeks after surgery: a comparison to standard knee arthroscopy. J Orthop. 2023;41:63-66.
- [Google Scholar]
- The role of outpatient needle arthroscopy in the diagnosis and management of musculoskeletal complaints: a systematic review of the Arthrex NanoScope. Knee. 2023;42:246-257.
- [Google Scholar]
- In-Office diagnostic needle arthroscopy using the NanoScope™ arthroscopy system. Arthrosc Tech. 2022;11:e1923-e1927.
- [Google Scholar]
- A prospective, blinded, multicenter clinical trial to compare the efficacy, accuracy, and safety of In-Office diagnostic arthroscopy with magnetic resonance imaging and surgical diagnostic arthroscopy. Arthroscopy. 2018;34:2429-2435.
- [Google Scholar]
- Opioid use after simple arthroscopic knee surgery. Am J Sports Med. 2022;50:1644-1650.
- [Google Scholar]
- Opioid consumption after Knee Arthroscopy. J Bone Joint Surg Am. 2018;100:1629-1636.
- [Google Scholar]

